COVID-19 Response: Local Logistics     National Effort

C-CAMP Non-Resident National and International Incubation Program (C-NRI)

You are here

COVID-19 Response: Local Logistics     National Effort

C-CAMP Non-Resident National and International Incubation Programme (C-NRI)

Centre for Cellular And Molecular Platforms (C-CAMP) has established itself as the leading Bio-Innovation Hub in India. It’s aptly located in Bangalore, the Indian Biotech Capital, and is thereforeclosely connected with all the stakeholders involved in the Indian innovation ecosystem. This connected network is continuously growing and includes scientists and research institutions, emerging and established entrepreneurs, government and private funding bodies, regulatory agencies, and the industry within Karnataka, throughout India and internationally as well. These connections are absolutely vital for transforming early-stage scientific ideas into impactful commercial innovations. C-CAMP offers incubation space, along with funding opportunities, mentorship, and other facilitation, to budding entrepreneurs. But you don’t have to be physically incubated at C-CAMP to be a part of C-CAMP’s Ecosystem. You can connect with C-CAMP as a ‘Non-resident Incubatee’.

 With strong demand for support from start-ups across India and beyond, C-CAMP is delighted to launch the C-CAMP Non-Resident National and International Incubation Programme (C-NRI). As a C-NRI portfolio start-up, you can connect with C-CAMP and it’s broad network and position yourself in the start-up eco-system gaining maximum benefit from what has become one of the most exciting Life Science Innovation Hubs in India.

Benefits

Model 1:

  • Becoming a part of C-CAMP portfolio to positioning yourself in the start-up eco-system gaining maximum benefit from what has become one of the most exciting Life Science Innovation Hubs in India.
  • Access to C-CAMP eco-system and network, which includes: a)scientists and research institutions, b) emerging and established entrepreneurs, c) government and private funding bodies & investors, d) regulatory agencies, e) IP firms, f) Hospitals/Farmer Organizations, g) CRO’s & Distributor network.
  • Networking opportunities with different stakeholders and players in India and globally.
  • Soft Landing and facilitation of interaction with Indian players for international incubatees
  • Bi-monthly call with C-CAMP Incubation team to understand and assess requirement and facilitate accordingly
  • Access to funding support which C-CAMP provides
  • Access all events, workshops and seminars conducted by C-CAMP
  • Access to high-end technology platforms and facilities at C-CAMP

Model 2:

  • Becoming a part of C-CAMP portfolio to positioning yourself in the start-up eco-system gaining maximum benefit from what has become one of the most exciting Life Science Innovation Hubs in India.
  • Access to the C-CAMP Entrepreneur Mentorship Program.   
  • Access to C-CAMP eco-system and network, which includes: a)scientists and research institutions, b) emerging and established entrepreneurs, c) government and private funding bodies & investors, d) regulatory agencies, e) IP firms, f) Hospitals/Farmer Organizations, g) CRO’s & Distributor network.
  • Networking opportunities with different stakeholders and players in India and globally.
  • Soft Landing and facilitation of interaction with Indian players for international incubatees
  • Bi-monthly call with C-CAMP Incubation team to understand and assess requirement and facilitate accordingly
  • Access to funding support which C-CAMP provides
  • Access all events, workshops and seminars conducted by C-CAMP
  • Access to high-end technology platforms and facilities at C-CAMP

Contact us at nri_incubation@ccamp.res.in for more information. 

Start-ups incubated under C-NRI Scheme

International Incubatees


Clemedi

Clemedi AG is a Swiss medical diagnostic company focusing on antibiotic resistance, established in 2019. Clemedi is a paradigm change.Using a combination of next-generation sequencing and AI for the first time, it produces comprehensive diagnoses at historical speed. This achieves 2 things: reduction in antibiotic misuse and dramatic slowing of antibiotic resistance, the next major human health challenge.

Website: https://clemedi.com/


Indian Non-Resident Incubatees


Abgenics LifeSciences Pvt. Ltd.

Abgenics is spearheading the development of unique antibodies, biologicals, drugs and diagnostics for human diseases based on an intimate understanding of disease biology and patient needs. Their technology is a new class of antimicrobials and companion diagnostics against top six drug resistant microbial pathogens. Called AbTids they are biologicals consisting of a pathogen specific heavy chain antibody derived from camels combined with antimicrobial peptides that are effective in the nanomolar range that will be deployed for accurate diagnostics and therapy of drug resistant superbugs.

Website: https://www.abgenics.in/


Invitreo

Invitreo specializes in materializing deep technology healthcare research through academia-industry collaboration.They identify the feasibility of the research in terms of its implications in healthcare and work towards materializing it into a commercially viable technology. They are currently working on longer-term animal trials & commercialisation of a Bioartificial Pancreas, developed by IIT Bombay for Type 1 Diabetes treatment. A Bioartificial Pancreas (BAP) contains pancreatic islets (allogeneic or xenogeneic) or differentiated islets encapsulated within a synthetic biocompatible semipermeable membrane and fully mimics the behaviour and function of a healthy pancreas Their product uses patented stem cell technology and short term trials have shown reversal of Diabetes for 30 days in mouse models

Website: http://www.invitreo.com/